Design
Review
Authors
Loading...
High complication rates and absent mortality benefit warrant caution against routine use; leaves open net clinical benefit in larger RCTs.
While percutaneous transvalvular microaxial flow pumps improve hemodynamics, their clinical outcome benefits remain unproven in large RCTs and they carry significant risks of bleeding, hemolysis, and stroke.
Lüsebrink et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: